Halozyme Therapeutics (HALO) Q1 Earnings and Revenues Miss EstimatesZacks Investment Research • 05/09/23
Strength Seen in Halozyme Therapeutics (HALO): Can Its 5.3% Jump Turn into More Strength?Zacks Investment Research • 03/21/23
HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL AND OPERATING RESULTSPRNewsWire • 02/21/23
Halozyme to Report Fourth Quarter and Full Year 2022 Financial and Operating ResultsPRNewsWire • 02/07/23
HALOZYME THERAPEUTICS, INC. ANNOUNCES REDEMPTION OF 1.25% CONVERTIBLE SENIOR NOTES DUE 2024PRNewsWire • 01/11/23
Halozyme Therapeutics (HALO) Up 16.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/08/22